SCHEMBL19081833

SCHEMBL19081833

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3ccc4oc5cc6c(cc5c4c3)sc3c4ccccc4ccc63)c3ccccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.37
CYP1B1 Q16678 4/20 0.37
CYP1A2 P05177 3/20 0.34
LIMK1 P53667 2/20 0.33
LIMK2 P53671 1/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
PLA2G10 O15496 1/20 0.33
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
HCRTR1 O43613 1/20 0.31
ANO1 Q5XXA6 1/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081981 0.95 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2LIMK1LIMK2
SCHEMBL19082051 0.92 CYP1A1 (0.33) CYP1A1CYP1B1CYP1A2MAPK1KMT2A
SCHEMBL19076738 0.91 DUSP3 (0.34) CYP1A1CYP1B1CYP1A2LIMK1LIMK2
SCHEMBL19081809 0.90 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2HCRTR1MAPK9
SCHEMBL19108881 0.88 PRKDC (0.34) CYP1A1CYP1B1CYP1A2PLA2G2APLA2G4A
SCHEMBL19081788 0.88 CYP1A1 (0.35) CYP1A1CYP1B1CYP1A2MAPK1KMT2A
SCHEMBL19082162 0.87 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2LIMK1LIMK2
SCHEMBL19081924 0.86 CYP1A1 (0.34) CYP1A1CYP1B1CYP1A2MAPK1KMT2A
SCHEMBL21579275 0.86 CYP1B1 (0.35) CYP1A1CYP1B1CYP1A2LIMK1PLA2G2A
SCHEMBL19076846 0.86 HCRTR1 (0.35) CYP1A1CYP1B1CYP1A2KMT2ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.